Skip to content
value.today

Cannmedica Pharma Inc.

Formerly 2384634 Ontario Inc., Cannamed Pharma Inc.

Total raised
$4 M
2 rounds on record
Latest round
$1 M
Dec 2014
First round on record
Jun 2014
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Cannmedica Pharma Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2014$1 MNo. 2Under $2 million

Cannmedica Pharma Inc.: Raise no. 2, Dec 2014

Investors in this round

2 investors had bought by the notice of Jan 6, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ontario, Canada

People named in the notice

  • Eric Paul · Executive Officer, Director
  • Norman Paul · Executive Officer, Director
  • Mark Litwin · Director
  • Mitchell J. Sanders · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$1,000,000 sold to 2 US Purchasers.”

Signed by Eric Paul, Director. Newest notice filed Jan 6, 2015. Read the notice at the SEC.

equitySEC
Jun 2014$3 MNo. 1$2 to $10 million

Cannmedica Pharma Inc.: Raise no. 1, Jun 2014

Investors in this round

14 investors had bought by the notice of Jul 10, 2014: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$114,983
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Ontario, Canada

People named in the notice

  • Eric Paul · Executive Officer, Director
  • Norman Paul · Executive Officer, Director
  • Mark Litwin · Director
  • Ron Benson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Bloom Burton & Co · Toronto, Ontario, CanadaSold in no state named, and outside the US

Remarks in the notice

  • On the amounts: “$23,222.69 sold to US purchaser. Remainder sold to non-US purchasers.”

Signed by Eric Paul, Director. Newest notice filed Jul 10, 2014. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cannmedica Pharma Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2015).

    SEC Form D · Jan 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2015

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cannmedica Pharma Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cannmedica Pharma Inc.
NameRoleNamed in
Eric PaulExecutive officerJan 2015
Norman PaulExecutive officerJan 2015
Eric PaulDirectorJan 2015
Mark LitwinDirectorJan 2015
Mitchell J. SandersDirectorJan 2015
Norman PaulDirectorJan 2015
Ron BensonDirectorJul 2014